Working Together to Find a Cure     Print Page | Close Window

2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015

April 25, 2017: Abeona Therapeutics Announces EB-101 Clinical Update to be Presented at the Society for Investigative Dermatology Annual Meeting

April 20, 2017: Abeona to Present At Multiple Upcoming Conferences

April 5, 2017: Abeona Announces Rare Disease Gene Therapy Symposium with the New York Academy of Sciences

March 31, 2017: Abeona Therapeutics Reports Q4 2016 Financial Results and Business Highlights

March 13, 2017: Abeona Therapeutics to Present at Multiple Upcoming Investor Conferences

March 8, 2017: Abeona Therapeutics Receives Orphan Drug Designation in the European Union for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa

March 7, 2017: Abeona Therapeutics To Present At The Cowen and Company 37th Annual Health Care Conference

March 3, 2017: Abeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in Shanghai

February 23, 2017: Abeona Therapeutics Announces Dismissal of Securities Class Action Lawsuit

February 21, 2017: Abeona Therapeutics to Present at the 2017 RBC Capital Markets Global Healthcare Conference and 3rd Annual CRISPR Congress

February 17, 2017: Abeona Therapeutics Provides Update from ABO-102 Phase 1/2 MPS IIIA Clinical Trial at the 13th Annual WORLDSymposium™ 2017

February 7, 2017: Abeona Therapeutics Announces Presentations and Posters at the 13th Annual WORLDSymposium™ 2017

February 1, 2017: Abeona Therapeutics Enrolls First High Dose Subject in Ongoing Phase 1/2 Gene Therapy Clinical Trial in Sanfilippo Syndrome Type A

January 19, 2017: Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-101 Gene Therapy in Sanfilippo Syndrome Type B

January 17, 2017: Abeona Therapeutics to Present at Phacilitate Cell & Gene Therapy World 2017

January 3, 2017: Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-201 Gene Therapy Program in Juvenile Batten Disease